146 related articles for article (PubMed ID: 21882108)
1. Development of paediatric medicines: concepts and principles.
Rose K; Della Pasqua O
Handb Exp Pharmacol; 2011; 205():111-24. PubMed ID: 21882108
[TBL] [Abstract][Full Text] [Related]
2. Efficacy assessment in paediatric studies.
Wang S; Laitinen-Parkkonen P
Handb Exp Pharmacol; 2011; 205():149-68. PubMed ID: 21882110
[TBL] [Abstract][Full Text] [Related]
3. Historical development of pediatric pharmacology.
Seyberth HW; Rane A; Schwab M
Handb Exp Pharmacol; 2011; 205():v-vi. PubMed ID: 22046631
[No Abstract] [Full Text] [Related]
4. Off licence and off label prescribing in children: litigation fears for physicians.
Hill P
Arch Dis Child; 2005 Feb; 90 Suppl 1(Suppl 1):i17-8. PubMed ID: 15665151
[TBL] [Abstract][Full Text] [Related]
5. Changing requirements for evaluation of pharmacologic agents.
Chesney RW; Christensen ML
Pediatrics; 2004 Apr; 113(4 Suppl):1128-32. PubMed ID: 15060209
[TBL] [Abstract][Full Text] [Related]
6. Medicines for children licensed by the European Agency for the Evaluation of Medicinal Products.
Ceci A; Felisi M; Catapano M; Baiardi P; Cipollina L; Ravera S; Bagnulo S; Reggio S; Rondini G
Eur J Clin Pharmacol; 2002 Nov; 58(8):495-500. PubMed ID: 12451425
[TBL] [Abstract][Full Text] [Related]
7. Pediatric regulatory initiatives.
Hirschfeld S; Saint-Raymond A
Handb Exp Pharmacol; 2011; 205():245-68. PubMed ID: 21882115
[TBL] [Abstract][Full Text] [Related]
8. Criteria supporting the study of drugs in the newborn.
Ward RM; Benitz WE; Benjamin DK; Blackmon L; Giacoia GP; Hudak M; Lasky T; Rodriguez W; Selen A
Clin Ther; 2006 Sep; 28(9):1385-98. PubMed ID: 17062311
[TBL] [Abstract][Full Text] [Related]
9. European Union pediatric legislation jeopardizes worldwide, timely future advances in the care of children with cancer.
Rose K
Clin Ther; 2014 Feb; 36(2):163-77. PubMed ID: 24529288
[TBL] [Abstract][Full Text] [Related]
10. Future developments of clinical research in pediatrics: the role of the Journal Klinische Pädiatrie.
Körholz D; Gortner L; Göbel U
Klin Padiatr; 2013 Jul; 225(4):191-2. PubMed ID: 23904155
[No Abstract] [Full Text] [Related]
11. Developing paediatric medicines: identifying the needs and recognizing the challenges.
Ernest TB; Elder DP; Martini LG; Roberts M; Ford JL
J Pharm Pharmacol; 2007 Aug; 59(8):1043-55. PubMed ID: 17725846
[TBL] [Abstract][Full Text] [Related]
12. Clinical programs in the development of similar biotherapeutic products: rationale and general principles.
Berghout A
Biologicals; 2011 Sep; 39(5):293-6. PubMed ID: 21911300
[TBL] [Abstract][Full Text] [Related]
13. Study design and simulation approach.
Läer S; Meibohm B
Handb Exp Pharmacol; 2011; 205():125-48. PubMed ID: 21882109
[TBL] [Abstract][Full Text] [Related]
14. Development of medicines for children in Europe: ethical implications.
Saint Raymond A; Brasseur D
Paediatr Respir Rev; 2005 Mar; 6(1):45-51. PubMed ID: 15698816
[TBL] [Abstract][Full Text] [Related]
15. The economics of pediatric formulation development for off-patent drugs.
Milne CP; Bruss JB
Clin Ther; 2008 Nov; 30(11):2133-45. PubMed ID: 19108801
[TBL] [Abstract][Full Text] [Related]
16. Family pediatrics: report of the Task Force on the Family.
Schor EL;
Pediatrics; 2003 Jun; 111(6 Pt 2):1541-71. PubMed ID: 12777595
[TBL] [Abstract][Full Text] [Related]
17. Are development times for pharmaceuticals increasing or decreasing?
Keyhani S; Diener-West M; Powe N
Health Aff (Millwood); 2006; 25(2):461-8. PubMed ID: 16522587
[TBL] [Abstract][Full Text] [Related]
18. Postmarketing surveillance.
Vlahović-Palčevski V; Mentzer D
Handb Exp Pharmacol; 2011; 205():339-51. PubMed ID: 21882120
[TBL] [Abstract][Full Text] [Related]
19. Testing medications in children.
Steinbrook R
N Engl J Med; 2002 Oct; 347(18):1462-70. PubMed ID: 12409558
[No Abstract] [Full Text] [Related]
20. Drug development process for a product with a primary pediatric indication.
Allen AJ; Michelson D
J Clin Psychiatry; 2002; 63 Suppl 12():44-9. PubMed ID: 12562061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
